iProtics

Leiden, The Netherlands

iProtics is revolutionizing the treatment of cancer and auto-immune disorders.

$383K raised

Oct 2024

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has iProtics raised?

iProtics has raised $383K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2024.

Who are iProtics's investors?

iProtics's investors include UNIIQ.

Where is iProtics headquartered?

iProtics is headquartered in Leiden, The Netherlands.

What does iProtics do?

iProtics is revolutionizing the treatment of cancer and auto-immune disorders.

What stage is iProtics at?

iProtics is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 9, 2024.

MLA

"iProtics — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/iprotics. Accessed July 2, 2026.

APA

VCBacked. (2024). iProtics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/iprotics

Wikipedia (cite web)

{{cite web |title=iProtics — Funding & Investors |url=https://www.vcbacked.co/company/iprotics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 9, 2024.